Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.77 |
| ▸ | TSHR | P16473 | 5/20 | 0.77 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | SCN1A | P35498 | 2/20 | 0.55 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.55 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1147852 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL28239832 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL451075 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL2385137 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL21800979 | 1.00 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL5407185 | 0.97 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL28106513 | 0.97 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL5407181 | 0.97 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL27975029 | 0.97 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 | |
| SCHEMBL28149248 | 0.97 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNAMAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107526256-B | Toner compositions with anti-plasticizers | 施乐公司 | 2023-04-07 | — | — | CN | disclosed |
| US-8394394-B2 | Mousse formulations | L'ORÉAL (FR) | 2013-03-12 | — | — | US | disclosed |
| CN-101460146-B | Vesicular formulations containing organic acid prodrugs and process for their preparation | UNIV LISBOA | 2013-01-09 | — | — | CN | disclosed |
| US-20120301415-A1 | COMPOSITIONS HAVING ENHANCED COSMETIC PROPERTIES | L'OREAL (FR) | 2012-11-29 | — | — | US | disclosed |
| US-8025869-B2 | Cosmetic compositions having enhanced wear properties | L'ORÉAL (FR) | 2011-09-27 | — | — | US | disclosed |
| CN-101917958-A | Powder cosmetic composition | AVON PROD INC | 2010-12-15 | — | — | CN | disclosed |
| US-7262158-B1 | Cleansing compositions comprising a liquid silicone and ester mixture | JOHNSON & JOHNSON COMPANIES, INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20070093619-A1 | Compositions having enhanced cosmetic properties | L'OREAL (FR) | 2007-04-26 | — | — | US | disclosed |
| EP-1758547-A1 | COSMETIC MOUSSE FORMULATIONS | L'OREAL (FR) | 2007-03-07 | — | — | EP | disclosed |
| US-20060292106-A1 | Shaving preparation | L'OREAL (FR) | 2006-12-28 | — | — | US | disclosed |
| CN-1385457-A | Gel composition | PANRICO PARTNERSHIP INC (US) | 2002-12-18 | — | — | CN | disclosed |
| EP-1216685-A2 | Personal care compositions | Johnson & Johnson Consumer Companies, Inc. (US) | 2002-06-26 | — | — | EP | disclosed |
| CN-1348815-A | Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use | TIANJIN TIANSHILI PHARMACEUTIC (CN) | 2002-05-15 | — | — | CN | disclosed |
| US-20020035046-A1 | Personal care compositions | JOHNSON & JOHNSON CONSUMER INC. | 2002-03-21 | — | — | US | disclosed |
| WO-2001001949-A9 | CLEANSING COMPOSITIONS | JOHNSON & JOHNSON CONSUMER (US) | 2001-03-22 | — | — | WO | disclosed |
| WO-2001001949-A1 | CLEANSING COMPOSITIONS | JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
| EP-0988019-A1 | COSMETIC COMPOSITIONS CONTAINING SMECTITE GELS | AVON PRODUCTS, INC. (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1999065455-A1 | GEL MATRIX NON-EMULSION COMPOSITION CONTAINING TWO CLAY GELS | AVON PRODUCTS, INC. (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5882662-A | COSMETICS WITH SMECTITE CLAY AND POLAR SOLVENTS | AVON PRODUCTS, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| WO-1998050003-A1 | COSMETIC COMPOSITIONS CONTAINING SMECTITE GELS | AVON PRODUCTS, INC. (US) | 1998-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035046-A1 | Personal care compositions | CUTA, DSG1, KRT18 | ALDH1A1 2534/4885TSHR 4229/4885LMNA 1546/4885 |
| US-20120301415-A1 | COMPOSITIONS HAVING ENHANCED COSMETIC PROPERTIES | RARA, CUTA, RXRA | ALDH1A1 1513/4885TSHR 2932/4885LMNA 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.